The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced ...
Drug and medical device maker ICON agrees to buy PRA Health Sciences in a cash-and-stock transaction valued at about $12 billion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results